LifeMax is a clinical stage biotech company with seasoned management team that has full-spectrum pharmaceutical industry experience including building a multi-billion US public company from ground up. The company's mission is to engage in R&D, manufacturing and commercialization of innovative pharmaceutical products that provide meaningful clinical benefit to patients.
LifeMax' R&D pipeline is focused on diseases that have few or no approved therapeutic options. Our product selection is based not only on unmet medical needs but also on unmet market need. Our balanced product portfolio includes mix of NCE’s/NME’s and re-purposing/re-position molecules to balance the development risk.